Transcript of Q2 FY25-26 earnings call notes multiple OEM programs (Maruti, Mahindra), ₹100 crore investment for ongoing programs, and prioritization of HCV deliveries; retrofit for small vehicles scaled back amid demand/regulatory concerns; Netherlands subsidiary stable; emphasis on core Indian business in Solapur with longer visibility.